CREAZITHRO Tablet

ក្រុមហ៊ុនផលិតឱសថ:

 

Laboratoire BAILLY-CREAT, France

  • សារធាតុសកម្ម
  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
  • ហាមប្រើ
  • ផលរំខាន
  • អន្តរប្រតិកម្ម
  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
  • បរិយាយប័ណ្ណឱសថ 
  • សារធាតុសកម្ម

  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់

    Indication:
    It is indicated for the treatment of infections due to sensitive bacteria.

    Dosage:

    Azithromycin tablets should be given as a single daily dose.

    The tablets should be swallowed preferably with a drink of water, and can be taken with or without food.

    Adults (including older patients), children and adolescents with a body weight of over 45kg:

    The recommended dose is 1500mg divided over either 3-5 days as follows:

    - When taken over 3 days, 500mg once daily.

    - When taken over 5 days, 500mg as a single dose on the first day and then 250mg once daily on days 2 through to 5.

    - Inflammation of the urethra or cervix caused by Chlamydia: 1000mg taken as a single dose, for one day only.

    For infections in your sinuses, treatment is indicated for adults and adolescents 16 years of age and over.

    Children and adolescents with a body weight of 45kg and under:

    Tablets are not indicated for these patients. Other pharmaceutical forms of azithromycin-containing products (e.g. suspensions) may be used.

    Patients with kidney or liver problems:

    You should tell your doctor.

    Duration of treatment

    To be effective, this drug should be used without interruption, at the prescribed doses and for as long as your doctor recommended.

  • ហាមប្រើ

    Hypersensitivity to one of the component,

    Liver failure,

    If you are taking the following medicines: medicines known as ergot alkaloids (such as ergotamine), cisapride, colchicine.

  • ផលរំខាន

    - Mucocutaneous and allergic disorders: rash, photosensitivity, arthralgia, urticaria, pruritus, rarely angioedema, anaphylactic reactions. Rare cases of severe skin reactions have been reported.

    - Gastrointestinal: nausea, vomiting, dyspepsia, diarrhea (rarely severe), abdominal pain, pancreatitis. Rare cases of pseudomembranous colitis have been reported.

    - Hepatic: elevated liver enzymes reversible on discontinuation. Rare cases of hepatic necrosis and rarely life-threatening hepatic failure. However, no causal link has been established.

    Isolated cases of cholestatic hepatitis have been reported.

    - Neurological: dizziness; rare cases of convulsions have been reported.

    - Hematologic: thrombocytopenia isolated cases have been reported.

    - Psychiatric: Rare cases of aggressive behavior, nervousness, agitation and anxiety have been reported.

    - Genital: vaginitis.

    - Hearing: rare cases of hearing disorders with tinnitus or hearing loss have been reported.

    - General: candidiasis.

  • អន្តរប្រតិកម្ម

    See "Contraindication".

  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន

    If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។

ប្រភពព័ត៌មាន៖

- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp

- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp